A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes
Ben Boursi(Tel Aviv University), Yu‐Xiao Yang(Philadelphia VA Medical Center), Andrew D. Rhim(Cancer Research Institute), Ronac Mamtani(Hospital of the University of Pennsylvania), Brian S. Finkelman(University of Pennsylvania), Kevin Haynes(University of Pennsylvania), Bruce J. Giantonio(Northwestern University), Anil K. Rustgi(Columbia University Irving Medical Center)
Cited by 193
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k